We don't want it, they can have it. The U.S. is sending millions of surplus doses of the AstraZeneca vaccine to Mexico and Canada, officials said. Thursday, March 18, 2021 1:11 PM EST https://www.nytimes.com/2021/03/18/world/americas/usa-mexico-vaccine-coronavirus.html Tens of millions of doses of the AstraZeneca vaccine have been sitting in American manufacturing sites. But while their use has already been authorized in dozens of countries, the vaccine has not yet been approved by U.S. regulators. The White House plans to send 2.5 million doses of the vaccine to Mexico and 1.5 million to Canada, according to a White House official, who said logistics on the plan were still being discussed. (More at above url)
This is dirty. The process of getting emergency review and approval of the AstraZ vaccine should be expedited to the max. If the vaccine has problems that do not allow for its approval then that needs to be fully determined and either approval is granted or it is rejected or specific more studies are required. Instead the swamp and the bureaucrats are killing the process to free up the vaccine for their side agendas. And avoiding criticism that they are giving away vaccines meant for Americans by pretending that the vaccines were never really available. They need to follow the science. That science could be up or down or change with more examination as is happening in other countries. Most likely that is a perfectly fine large source of good vaccine that has issues that need to be monitored, as is true of every other approved drug on the market. Dirty. Very dirty. Now, Biden puts the CDC and FDA in a bind where they cannot approve conditional and emergency use for the vaccine because it would undermine Biden's plan to score political points with Mexico and Canada by giving them the vaccine. Dirty. One of the side problems of course is that Mexico just started this week distributing the Sputnik vaccine and Biden knows that he is not the only player in the game to influence Mexico.
Something to consider with this line of thinking is that we implemented the vaccine development plan based on what the Gates Foundation recommended. Meaning we funding multiple vaccines for development with different mechanisms of efficacy, expecting some to fail or not meet our standards. The MRNA shots have exceeded our expectations and considering we’ve been giving shots since late December there’s not much safety concern at this point. So, along with Pfizer and Moderna, we also have a one shot J&J vaccine. Which is plenty considering we are pumping out 22 million doses a week now. Our biggest problem actually people and places to give the shot right now. So, I’m not against not using the AZ shot for a number of reasons from its as effective as what we already have to we don’t have the capacity to administer more shots to I’m not convinced it meets a safety profile we can be sure of. Giving away the shots is something else entirely though. And I’m not sure how much the American Public would accept the AZ shot when we have 3 other vaccines that are growing in confidence.
What a bootlicking crock you have just unloaded. Trump and the scientific community proceeded full speed ahead to bring all possible vaccines to market. Now, rather than letting the vaccine be approved/not approved by the process and the "experts" you are getting in front of the process - to help Joe- by running ahead of it and announcing that the public would be reluctant to take it, or might be. That's just complete bullshit to let Joe off the hook. We have some perfectly fine vaccines that the public is already reluctant to take. That is a different issue than what the CDC and FDA are being asked to determine. You are a a disappointment. It only confirms what a good job Trump did in making sure that the process moved ahead. It is clear that once Biden and his clown supporters get involved, all sorts of side diversions immediately set in.
My question is how long can these AstraZeneca doses be stored for before they are ineffective. My understanding is that these particular AstraZeneca doses arrived in the U.S. in late Jan / early Feb. It appears that approval for AstraZeneca in the U.S. will be delayed. They were originally targeting the start of April. Now the FDA is demanding the results of the clot investigation in Europe to be submitted and further scrutiny of the 30,000 Phase 3 trial participants in the U.S. for clots. This will delay the possible approval date.
Why were the Americans not simultaneously reviewing the results along with the Europeans? This is an emergency situation. These vaccines should be offered to Americans before leaving the country. If that requires a waiver or something- do it. It is not the job of the FDA to ensure that there are no issues anywhere. The standard is "does the proposed drug provide benefits that exceed the risks." The the Brits, the Europeans and the Canadians have already determined that it does. And now that Trump is gone, we are back to the same swamp footdragging political forces that required 4-8 years for a vaccine to reach market.
Biden announced will reach 100 million shots tomorrow. Nice And... There will be enough vaccine available for every adult by the end of May. Fantastic Big logistical problems actually getting the shots into people’s arms though...
By the way the way the AstraZeneca vaccine can be stored up to six months. https://www.prevention.com/health/a35118263/astrazeneca-vs-pfizer-vs-moderna-covid-19-vaccine/ The U.S. is sitting on 30 million AstraZeneca doses in West Chester, Ohio. We have 300 million doses AstraZeneca ordered which are not likely to be delivered until the second half of the year. The U.S. Is Sitting on Tens of Millions of Vaccine Doses the World Needs Those tens of millions of doses from AstraZeneca are waiting for trial results, while countries that authorized the vaccine beg to have them. https://www.nytimes.com/2021/03/11/us/politics/coronavirus-astrazeneca-united-states.html It is likely that we only sent 4 million AstraZeneca doses to Canada and Mexico that were likely to expire before any possible approval in the U.S. in the April timeframe.